Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Clin Respir J ; 18(6): e13775, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38830831

ABSTRACT

Pulmonary heart disease (PHD) involves altered structure and function of the right ventricle caused by an abnormal respiratory system that causes pulmonary hypertension. However, the association between changes in plasma proteomics and PHD remains unclear. Hence, we aimed to identify causal associations between genetically predicted plasma protein levels and PHD. Mendelian randomization was performed to test the target proteins associated with PHD. Summary statistics for the human plasma proteome and pulmonary heart disease were acquired from the UK Biobank (6038 cases and 426 977 controls) and the FinnGen study (6753 cases and 302 401 controls). Publicly available pQTLs datasets for human plasma proteins were obtained from a largescale genome-wide association study in the INTERVAL study. The results were validated using a case-control cohort. We first enrolled 3622 plasma proteins with conditionally independent genetic variants; three proteins (histo-blood group ABO system transferase, activating signal cointegration 1 complex subunit 1, and calcium/calmodulin-dependent protein kinase I [CAMK1]) were significantly associated with the risk of pulmonary heart disease in the UK Biobank cohort. Only CAMK1 was successfully replicated (odds ratio: 1.1056, 95% confidence interval: 1.019-1.095, p = 0.0029) in the FinnGen population. In addition, the level of CAMK1 in 40 patients with PHD was significantly higher (p = 0.023) than that in the control group. This work proposes that CAMK1 is associated with PHD, underscoring the importance of the calcium signaling pathway in the pathophysiology to improve therapies for PHD.


Subject(s)
Genome-Wide Association Study , Mendelian Randomization Analysis , Proteome , Pulmonary Heart Disease , Humans , Mendelian Randomization Analysis/methods , Genome-Wide Association Study/methods , Male , Female , Proteome/metabolism , Case-Control Studies , Pulmonary Heart Disease/genetics , Pulmonary Heart Disease/blood , Pulmonary Heart Disease/epidemiology , Middle Aged , United Kingdom/epidemiology , Blood Proteins/genetics , Blood Proteins/metabolism , ABO Blood-Group System/genetics , Aged , Proteomics/methods , Adult , Polymorphism, Single Nucleotide
2.
Eur J Med Genet ; 64(6): 104209, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33766794

ABSTRACT

We present a male infant with alveolar capillary dysplasia without misalignment of pulmonary veins, hyperinflammation, megalocornea and macrosomia/macrocephaly at birth. Whole-exome sequencing revealed a homozygous 2bp-insertion in the latent transforming growth factor-beta binding protein 2 (LTBP2) (c.278_279dup, p.(Ser94Glyfs*187)). So far, LTBP2-variants have been frequently reported with an eye-restricted phenotype including primary congenital glaucoma and megalocornea/microspherphakia and ectopia lentis with/without secondary glaucoma. Hitherto reported systemic phenotypes showed, among others, features as tall stature, finger anomalies, high-arched palate and cardiovascular anomalies. The main pathophysiological finding of our patient was an alveolar capillary dysplasia (with pulmonary arterial hypertension and right ventricular impairment but without misalignment of pulmonary veins) resulting in almost continuous oxygen demand and prolonged dependence on mechanical ventilation. He died of respiratory failure at the age of seven months. This patient may extend the LTBP2-related phenotype with resulting diagnostic implications.


Subject(s)
Eye Diseases, Hereditary/genetics , Genetic Diseases, X-Linked/genetics , Glaucoma/genetics , Latent TGF-beta Binding Proteins/genetics , Persistent Fetal Circulation Syndrome/genetics , Phenotype , Pulmonary Alveoli/abnormalities , Pulmonary Heart Disease/genetics , Eye Diseases, Hereditary/pathology , Genetic Diseases, X-Linked/pathology , Glaucoma/pathology , Humans , Infant , Male , Persistent Fetal Circulation Syndrome/pathology , Pulmonary Alveoli/pathology , Pulmonary Heart Disease/pathology , Pulmonary Veins/abnormalities
3.
Eur Rev Med Pharmacol Sci ; 23(18): 8109-8114, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31599438

ABSTRACT

OBJECTIVE: To explore the correlations of interleukin-6 (IL-6) and C-reactive protein (CRP) gene polymorphisms with pulmonary heart disease (PHD). PATIENTS AND METHODS: A total of 98 patients with PHD and 102 healthy persons receiving physical examinations were enrolled. Their general clinical information was collected, and the levels of IL-6 and CRP in the plasma were determined. The pulmonary functions and blood gas were detected, and the TaqMan-minor groove binder (MGB) probe was used to detect the polymorphisms of IL-6 rs1800796 and CRP rs1800796. RESULTS: Observation group had higher levels of IL-6 and CRP than control group (p<0.05). The forced expiratory volume in 1 second (FEV1) (%), FEV1/forced vital capacity (FVC) ratio (%), and arterial partial pressure of oxygen (PaO2) in observation group were lower than those in control group (p<0.05), but the arterial partial pressure of carbon dioxide (PaCO2) was higher than that in control group (p<0.05). There were differences in the distribution frequencies of the genotypes and alleles of IL-6 rs1800796 and CRP rs1800796 between the two groups (p<0.05). CONCLUSIONS: IL-6 and CRP are correlated with the onset of PHD, and there are also correlations between the polymorphisms of IL-6 rs1800796 and CRP rs2794521 and the disease.


Subject(s)
C-Reactive Protein/genetics , Interleukin-6/genetics , Pulmonary Heart Disease/genetics , Blood Gas Analysis , Carbon Dioxide/metabolism , Case-Control Studies , Female , Forced Expiratory Volume , Genetic Predisposition to Disease , Humans , Male , Middle Aged , Oxygen/metabolism , Partial Pressure , Polymorphism, Single Nucleotide , Pulmonary Heart Disease/metabolism , Pulmonary Heart Disease/physiopathology , Vital Capacity
4.
Bull Exp Biol Med ; 166(4): 487-488, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30783842

ABSTRACT

The regulatory and adaptive status was determined in 202 healthy subjects by the parameters of the cardiorespiratory synchronism probe. We performed molecular-genetic analysis of polymorphic variants of the main gene of serotonin biosynthesis, tryptophan hydroxylase TPH1 (A218C polymorphism) and TPH2 (G703T polymorphism), and serotonin receptors (HTR2C and HTR2A genes). The association of the regulatory and adaptive status of a subject with the polymorphism of serotonergic mediator system genes was revealed.


Subject(s)
Polymorphism, Single Nucleotide/genetics , Pulmonary Heart Disease/genetics , Adolescent , Adult , Gene Frequency/genetics , Genetic Predisposition to Disease/genetics , Genotype , Humans , Male , Neurotransmitter Agents/metabolism , Receptor, Serotonin, 5-HT2A/genetics , Receptor, Serotonin, 5-HT2C/genetics , Serotonin/metabolism , Tryptophan Hydroxylase/genetics , Young Adult
5.
Mol Med Rep ; 14(1): 661-70, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27221156

ABSTRACT

Coronary heart disease (CHD), idiopathic pulmonary arterial hypertension (IPAH) and pulmonary heart disease (PHD) are circulatory system diseases that may simultaneously emerge in a patient and they are often treated together in clinical practice. However, the molecular mechanisms connecting these three diseases remain unclear. In order to determine the multidimensional characteristic correlations between these three diseases based on genomic networks to aid in medical decision-making, genes from the Online Mendelian Inheritance in Man database were obtained, and applied network construction and modularized analysis were conducted. Functional enrichment analysis was conducted to explore the associations between overlapping genes, modules and pathways. A total of 29 overlapping genes and 3 common modules were identifed for the 3 diseases. Glycosphingolipid biosynthesis and the arachidonic acid metabolism are common pathways, and the biosynthetic process is suggested to be the major function involved in the three diseases. The current study reported, to the best of our knowledge for the first time, the role of glycosphingolipid biosynthesis in IPAH and PHD. The present study provided an improved understanding of the pathological mechanisms underlying CHD, IPAH and PHD. The overlapping genes, modules and pathways suggest novel areas for further research, and drug targets. The observations of the current study additionally suggest that drug indications can be broadened because of the presence of common targets.


Subject(s)
Coronary Artery Disease/genetics , Familial Primary Pulmonary Hypertension/genetics , Genetic Association Studies , Genetic Predisposition to Disease , Pulmonary Heart Disease/genetics , Computational Biology/methods , Coronary Artery Disease/complications , Databases, Genetic , Epistasis, Genetic , Familial Primary Pulmonary Hypertension/complications , Gene Ontology , Gene Regulatory Networks , Humans , Models, Biological , Pulmonary Heart Disease/complications
6.
J Appl Physiol (1985) ; 102(5): 1780-5, 2007 May.
Article in English | MEDLINE | ID: mdl-17272409

ABSTRACT

Cor pulmonale is a significant cause of morbidity and mortality in patients with emphysema, but it is not known whether alveolar destruction is directly involved in the disease pathogenesis. The purpose of this study was to examine the relationship between susceptibility to smoking-induced cor pulmonale and alveolar destruction in eight inbred strains of mice: 129XI/SvJ, A/J, A/HeJ, BALB/cJ, C3H/HeJ, C57BL/6J, DBA/2J, and SWR/J. The mice were exposed to filtered air or mainstream cigarette smoke at a concentration of 250 mg/m(3) for 5.5 h/day, 5 days/wk for 5 mo, housed for 4 more months, and killed. The ratio of the weight of the right ventricle/left ventricle plus septum [RV/(LV + S)] was used to assess right ventricular hypertrophy. Alveolar mean linear intercept was used to quantify severity of alveolar destruction. Morphometric determination of blood vessel muscularization was done on sections from four mouse strains. Smoke exposure resulted in significant increases in RV/(LV + S) in the A/J and A/HeJ strains compared with air-exposed controls. The magnitude of the smoking-induced increase in RV/(LV + S) decreased as a function of the genetic distance of the other strains from the A/J and A/HeJ strains. Pulmonary vascular muscularization was significantly increased in smoke-exposed A/J and BALB/cJ mice but not in C3H/HeJ and C57BL/6 mice. Also, mouse strain susceptibility to smoking-induced pulmonary vascular muscularization did not correlate with changes in mean linear intercept. The data from this study suggest that alveolar destruction by itself is not sufficient to cause smoking-induced cor pulmonale in inbred mice.


Subject(s)
Genetic Variation , Hypertension, Pulmonary/etiology , Pulmonary Emphysema/complications , Pulmonary Heart Disease/etiology , Animals , Disease Models, Animal , Female , Genetic Predisposition to Disease , Heart Ventricles/pathology , Hypertension, Pulmonary/genetics , Hypertension, Pulmonary/pathology , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , Mice, Inbred C57BL , Mice, Inbred DBA , Muscle, Smooth, Vascular/pathology , Pulmonary Alveoli/pathology , Pulmonary Artery/pathology , Pulmonary Emphysema/etiology , Pulmonary Emphysema/genetics , Pulmonary Emphysema/pathology , Pulmonary Heart Disease/genetics , Pulmonary Heart Disease/pathology , Pulmonary Veins/pathology , Severity of Illness Index , Smoke , Species Specificity , Nicotiana
8.
Am J Respir Crit Care Med ; 166(10): 1396-402, 2002 Nov 15.
Article in English | MEDLINE | ID: mdl-12406857

ABSTRACT

Previous studies have suggested a genetic component in susceptibility to hypoxia-induced pulmonary hypertension. We therefore estimated the prevalence of high-altitude pulmonary hypertension (HAPH) in a Kyrgyz population and whether the insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene associates with HAPH. An electrocardiographic survey of 741 highlanders demonstrated electrocardiogram signs of cor pulmonale in 14% of subjects. Pulmonary artery hemodynamics measured in an independent group of 136 male highlanders with symptoms of dyspnea at altitude revealed established pulmonary hypertension (mean pulmonary artery pressure [MPAP] > or = 25 mm Hg) in 20%. However, 26% of the normal subjects demonstrated an exaggerated response (twofold or greater increase in MPAP) to inhalation of 11% oxygen, and were classified as hyperresponsive. Ten-year follow-up of this group revealed increases in the MPAP, but not in normal subjects. Comparison of ACE I/D genotypes in the catheterized group revealed a threefold higher frequency of the I/I genotype in highlanders with HAPH, compared with normal highlanders (chi2 = 11.59, p = 0.003). In addition, MPAP was higher in highlanders with the I/I genotype (26.9 +/- 4.0 mm Hg) compared with the I/D genotype (20.6 +/- 1.2 mm Hg) or the D/D genotype (18.3 +/- 0.9 mm Hg) (p < 0.05). We conclude that HAPH is associated with ACE I/D genotype among Kyrgyz highlanders and the development of HAPH in this population and may be predicted by hyperresponsiveness to acute hypoxia.


Subject(s)
Hypertension, Pulmonary/genetics , Adolescent , Adult , Aged , Airway Resistance/physiology , Bacterial Outer Membrane Proteins/genetics , Bacterial Outer Membrane Proteins/metabolism , Cardiac Catheterization , Electrocardiography , Female , Forced Expiratory Volume/physiology , Gene Frequency/genetics , Genetic Markers/physiology , Genetic Predisposition to Disease/genetics , Genotype , Heart Ventricles/pathology , Humans , Hypertension, Pulmonary/blood , Hypertension, Pulmonary/epidemiology , Kyrgyzstan/epidemiology , Lung/blood supply , Lung/pathology , Male , Membrane Glycoproteins/genetics , Membrane Glycoproteins/metabolism , Middle Aged , Peptidyl-Dipeptidase A/genetics , Peptidyl-Dipeptidase A/metabolism , Polymorphism, Genetic/genetics , Prevalence , Pulmonary Heart Disease/blood , Pulmonary Heart Disease/epidemiology , Pulmonary Heart Disease/genetics , Pulmonary Wedge Pressure/physiology , Vital Capacity/physiology
9.
Blood ; 100(7): 2487-93, 2002 Oct 01.
Article in English | MEDLINE | ID: mdl-12239160

ABSTRACT

Identification of a novel therapy for prevention of sudden death by ischemic cardiac infarction is an area of intensive investigation. We here report that the mortality due to an experimental acute myocardial infarction (AMI) was markedly increased in mice deficient in alpha2-antiplasmin (alpha2-AP(-/-) mice) but not in mice deficient in other components acting in fibrinolysis (tissue-type PA, urokinase type PA, or plasminogen activator inhibitor-1) even if the infarct area in alpha2-AP(-/-) mice was not different from those in the other mice. Echocardiography showed in alpha2-AP(-/-) mice after AMI an overload of the right ventricle and that pulmonary permeability was increased. According to the experiments using explanted myocytes and vascular smooth muscle cells, it was found that the amount of secreted vascular endothelial cell growth factor (VEGF) in alpha2-AP(-/-) mice was markedly increased compared with that in wild-type mice. Finally, an injection of an anti-VEGF antibody decreased the mortality after AMI in alpha2-AP(-/-) mice. Plasmin cleaves extracellular matrix-bound VEGF to release a diffusible proteolytic fragment and is inactivated mainly by alpha2-AP. Therefore, lack of alpha2-AP could markedly result in overrelease of VEGF by the continuous activation of plasmin because of AMI and could result in an acute cor pulmonale. Our results provide new aspects on the role of alpha2-AP and VEGF in the pathogenesis of cardiac events.


Subject(s)
Endothelial Growth Factors/metabolism , Intercellular Signaling Peptides and Proteins/metabolism , Lymphokines/metabolism , Myocardial Infarction/physiopathology , Pulmonary Heart Disease/genetics , alpha-2-Antiplasmin/physiology , Animals , Echocardiography , Endothelial Growth Factors/blood , Endothelial Growth Factors/genetics , Intercellular Signaling Peptides and Proteins/blood , Intercellular Signaling Peptides and Proteins/genetics , Lung/pathology , Lymphokines/blood , Lymphokines/genetics , Mice , Mice, Knockout , Myocardial Infarction/diagnostic imaging , Myocardial Infarction/pathology , Pulmonary Heart Disease/pathology , Pulmonary Heart Disease/physiopathology , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors , alpha-2-Antiplasmin/deficiency , alpha-2-Antiplasmin/genetics
11.
Q J Med ; 48(191): 419-28, 1979 Jul.
Article in English | MEDLINE | ID: mdl-317359

ABSTRACT

The clinical and radiological features of 23 patients with cor pulmonale due to chronic obstructive airways disease were reviewed. Twenty-two patients had evidence of pulmonary vascular disease and 52 per cent had secondary polycythaemia. Eighteen (78 per cent) had radiological evidence of emphysema. Thirteen of the patients (56.5 per cent) had alpha 1-antitrypsin phenotypes associated with serum deficiency and of these the largest single group was the MZ phenotype (34.8 per cent). No difference was found between the clinical features of patients with the MM phenotype or those associated with alpha 1-antitrypsin deficiency, although radiological emphysema was more common in the latter group (92 per cent compared to 60 per cent).


Subject(s)
Lung Diseases, Obstructive/complications , Pulmonary Heart Disease/genetics , alpha 1-Antitrypsin/genetics , Aged , Blood Gas Analysis , Humans , Phenotype , Pulmonary Heart Disease/etiology , Pulmonary Heart Disease/physiopathology , Respiratory Function Tests , alpha 1-Antitrypsin/metabolism
12.
Birth Defects Orig Artic Ser ; 10(4): 118-26, 1974.
Article in English | MEDLINE | ID: mdl-4377865

ABSTRACT

Approximately 20 inherited disorders of kidney transport occurring in man have so far been defined. Most of these diseases have characteristic clinical profiles. They can be divided into four groups: 1) the amino acid transport mutations which include the cystinurias, hyperdibasicaminoaciduria, Joseph syndrome, Hartnup disease, and the methionine malabsorption syndrome: 2) the sugar transport mutations characterized by glucose (renal glucosuria), and glucose-galactose malabsorption; 3) the electrolyte and water transport disorders, among which are familial hypophosphatemic rickets, vitamin D-dependent rickets, pseudohypoparathyroidism, proximal and distal renal tubular acidosis, and nephrogenic diabetes insipidus; and 4) the "mixed" kidney transport mutations such as the "Busby", Fanconi, Lowe, Luder-Sheldon syndromes, and glucoglycinuria.


Subject(s)
Phenotype , Renal Tubular Transport, Inborn Errors/genetics , Abnormalities, Multiple/genetics , Acidosis, Renal Tubular/genetics , Cerebrospinal Fluid Proteins , Chronic Kidney Disease-Mineral and Bone Disorder/genetics , Cystinuria/genetics , Diabetes Insipidus/genetics , Galactose/metabolism , Glucose/metabolism , Glycosuria, Renal/genetics , Growth Disorders/genetics , Hartnup Disease/genetics , Humans , Hypophosphatemia, Familial/genetics , Kidney Tubules/abnormalities , Malabsorption Syndromes/metabolism , Methionine/metabolism , Pseudohypoparathyroidism/genetics , Pulmonary Heart Disease/genetics , Renal Aminoacidurias/genetics , Seizures/genetics , Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL
...